Thermal Energy Receives Purchase Order from Royal National Orthopaedic
Hospital in England
OTTAWA, July 12 /CNW Telbec/ - Thermal Energy International Inc. (TSX-V: TMG) (www.thermalenergy.com) ("Thermal Energy" or "the company") is pleased to announce that on July 9th, 2010 it received a purchase order for (pnds stlg)261 thousand (approximately CDN $407 thousand) from Royal National Orthopaedic Hospital Trust, a major hospital just outside London, to provide a FLU-ACE(R) heat recovery solution for use on its heating and hot water system. The purchase order has now been received and execution of the project will be, approximately, over the next 20 weeks.
The purchase order was issued following the successful supply and installation of a GEM(R) condensate return system also from Thermal Energy 5 years earlier.
The Heat recovery project is calculated by Thermal Energy to return 1,129 tonnes of CO(2) and reduce energy consumption by just under 6 million kW annually providing a payback in just over 18 months for the Trust.
"The Trust is keen to see the benefits from this technology, after the previous successes with Thermal Energy at this and other hospitals in the UK, as well as internationally", commented Matt Hardy, General Estates Manager, Royal National Orthopaedic Hospital Trust.This important project will significantly reduce energy consumption for the Royal National Orthopaedic Hospital Trust and help towards the key targets of reducing carbon emissions by 80% by the year 2050 now set by the UK Government and will help to assure Thermal Energy's part in the National Health Service ("NHS") sustainability program.
"Thermal Energy has worked closely with the NHS in the UK over the last several months and has supported many activities, including being a headline sponsor for the NHS's Sustainability Development Units conference -One future, different paths. Yet another project from the NHS for Thermal Energy shows the rewards of all the hard work carried out to date," said Thermal Energy President and CEO William Crossland.
About National Health Services
NHS is the publicly funded healthcare system in Great Britain. According to its web site, the NHS is the largest single organization by employment in Europe, employing 5 per cent of the UK workforce and producing more than 18 million tonnes of CO2 per year - 3.2 per cent of carbon emissions and 25 per cent of public sector emissions in England. The NHS is the largest public sector contributor to climate change and is working vigorously to reduce its energy consumption by 80% by 2050 against a baseline use in 2000, a legal limit set by the UK Government. The NHS Sustainable Development 2010 - One Future, Different Paths Conference and Exhibition aimed to identify the progress to date and define the challenges moving forward in creating a sustainable NHS legacy for the future. This is set within the context of the current regulatory framework and policy mandate for the UK under the groundbreaking Climate Change, Planning and Energy Acts. Taken together, these provide an action plan to secure a Low Carbon Future and reduce carbon emissions by 10 per cent below 1990 levels by 2010, 34 per cent by 2020, and 80 per cent by 2050, according to govtoday.co.uk, an online resource for the public sector in the UK.
About Royal National Orthopaedic Hospital NHS Trust
The Royal National Orthopaedic Hospital NHS Trust (RNOH) founded in 1905 with the amalgamation of London's three specialist orthopaedic hospitals into a single centre of excellence and can trace its history back over 150 years to 1838. Sited on 2 sites, the main site is located in 112 green belt acres at Stanmore near London. Unique in the NHS (National Health Service), the RNOH provides a comprehensive range of neuro-musculoskeletal health care, ranging from the most acute spinal injury or complex bone tumour to orthopaedic medicine and specialist rehabilitation for chronic back pain sufferers. In addition the RNOH also plays a major role in teaching orthopaedic surgeons, with 20% receiving specialist training here.
About Thermal Energy
Thermal Energy International Inc. is an innovative clean technology company providing a variety of proprietary and proven energy efficiency, emission reduction, water efficiency and bioenergy products and solutions to the industrial, commercial and institutional markets worldwide. Thermal Energy's products include; GEM(R) - Steam traps and condensate return systems, FLU-ACE(R) - Direct contact condensing heat recovery, and Dry RexTM - Low temperature biomass drying systems. With offices in Ottawa, Canada and Bristol UK, Thermal Energy International Inc. is a fully accredited professional engineering firm, and offers advanced process and applications engineering services. FLU-ACE(R), GEM(R), DRY-REX(R), THERMALONOx(R), and THERMAL AUD(R) are trademarks of Thermal Energy International. To find out more about Thermal Energy International Inc. (TSX-V: TMG), visit our website at http://www.thermalenergy.com.
NOTE: This press release contains forward-looking statements relating to, and amongst other things, based on management's expectations, estimates and projections with respect to, expected agreement on and execution of definitive agreements, timing of installation and implementation, the anticipated effectiveness of the Company's products and services and the revenues to be received by the Company from the project described. Statements with respect to anticipated effectiveness of the Company's products and services are based on studies conducted by the Company and third parties as well as the Company's experience with similar installations for other customers. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, some of which are outside of the Company's control, could cause events and results to differ materially from those stated. The Company disclaims any obligation to publicly update or revise any such statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information: William Crossland, President and CEO, 613-723-6776
Share this article